by European Public Health Alliance | Dec 8, 2016 | Opinion
Following the signature of the Comprehensive Economic and Trade Agreement (CETA) at the EU-Canada Summit on 30 October 2016, the European Parliament and national parliaments across the EU now have to approve or reject the deal. The past month has seen an unprecedented...
by European Public Health Alliance | Dec 8, 2016 | Opinion
In November, the European Commission published its Annual Growth Survey 2017 (AGS), a key document setting out the main EU economic priorities for the coming year. The AGS kickstarts the annual cycle of the European Semester Process and will be followed by the...
by EPHA | Dec 8, 2016 | Opinion
Many medicines are increasingly becoming unaffordable. Many ‘new’ medicines turn out to be no more effective than those already being used. Global health needs are not driving medical research and development. Today, access to medicines has become a global...
by European Public Health Alliance | Dec 8, 2016 | Opinion
The European Commission recently hosted the 10th The European Platform for Roma Inclusion – a major conference dedicated to Roma integration, bringing together national governments, the EU, international organisations and Roma civil society representatives, aiming to...
by European Public Health Alliance | Dec 8, 2016 | Opinion
By Yannis Natsis, Policy Co-ordinator Universal Access and Affordable Medicines EPHA’s 2016 Universal Access & Affordable Medicines Forum, co-organised with the Polish Permanent Representation to the European Union, fostered genuine dialogue with key participants...
by EPHA | Dec 7, 2016 | Opinion, Statements
The EU recently concluded a new free trade deal with Canada – the Comprehensive Economic and Trade Agreement, or CETA for short. The deal has considerable side effects for people and public policy making. It has the potential to undermine public health by opening the...
